Food & Drug Law

Laurie J. Beyranevand & Emily M. Broad Leib, Making the Case for a National Food Strategy in the United States, 72 Food & Drug L.J.

Baylen J. Linnekin, Susan A. Schneider, Emily Broad Leib, Margaret Sova McCabe, Laurie Ristino & Michael Roberts, The Future of Food Law & Policy: The…

Emily Broad Leib et al., Fresh Look At Organics Bans And Waste Recycling Laws, 57 BioCycle 16 (2016).

Baylen J. Linnekin & Emily M. Broad Leib, Food and the Law, in Routledge International Handbook of Food Studies 238 (Ken Albala ed., 2013).

Robert Greenwald, Phillip Waters & Sarah Cayer, Enforcement of Legal Remedies to Secure Hepatitis C Virus Treatment With Direct-Acting Antiviral Therapies in Correctional Facilities and…

Sara Gerke, Boris Babic, Theodoros Evgeniou & I. Glenn Cohen, The Need For a System View to Regulate Artificial Intelligence/Machine Learning-Based Software as Medical Device,…

John H. Rex, Holly Fernandez Lynch, I. Glenn Cohen, Jonathan J. Darrow & Kevin Outterson, Designing Development Programs for Non-Traditional Antibacterial Agents, 10 Nature Comm.

Carmel Shachar, Eric Bressman & Ariel D. Stern, Carrots and Sticks: Incentives in Shaping Digital Health Products, 26 The American Journal of Bioethics 22 (2026).

Sara Gerke, Ravi B. Parikh & I. Glenn Cohen, Utah’s Prescription-Renewal Pilot Program—Autonomous AI Managing Patient Care, 394 The New England Journal of Medicine (2026).

I. Glenn Cohen, Holly Fernandez Lynch & Amy L. McGuire, The Psychedelic Therapies Executive Order, JAMA (2026).

Carmel Shachar, Tess Wise, Gali Katznelson, et al., Criminal Justice or Public Health: A Comparison of the Representation of the Crack Cocaine and Opioid Epidemics…

Stephan Lewandowsky, Philipp Schmid, Katrine Bach Habersaat et al., Lessons from COVID-19 for behavioural and communication interventions to enhance vaccine uptake, 1 Commc’ns Psych. (2023).

Alex K. Gearin, I. Glenn Cohen & Albert Garcia-Romeu, Setting, context and the regulatory atmospheres of psychedelic medicine, 153 International Journal of Drug Policy (2026).

Daniel G. Aaron, Eli Y. Adashi & I. Glenn Cohen, The US FDA’s New Rule for Regulating Laboratory-Developed Tests, 5 JAMA Health F. (2024).

Amy L. McGuire, I. Glenn Cohen, Dominic Sisti et al., Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement, 7 JAMA…

Holly Fernandez Lynch, Peter Lurie & I. Glenn Cohen, Checks and Balances on FDA’s Authority, JAMA (2024).

Eli Y. Adashi, I. Glenn Cohen & Allen J. Wilcox, The FDA Declares Levonorgestrel a Nonabortifacient—A 50-Year Saga Takes a Decisive Turn, 8 JAMA Health…

Amy L. McGuire, Holly Fernandez Lynch, Lewis A. Grossman et al., Pressing Regulatory Challenges for Psychedelic Medicine, 380 Science 347 (2023).

Effy Vayena, Alessandro Blasimme & I. Glenn Cohen, Machine Learning in Medicine: Addressing Ethical Challenges, 15 PLoS Med. e1002689 (2018).

Nathan G. Cortez, I. Glenn Cohen & Aaron S. Kesselheim, FDA Regulation of Mobile Health Technologies, 370 New Eng. J. Med. 372 (2014).

S. Sean Tu & Rebecca Tushnet, Free Speech Challenges to the Inflation Reduction Act, JAMA (2023).